Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marie‐France Fassotte
Observed names:
M F Fassotte,
M. F. FASSOTTE,
M. Fassotte,
M.-F. Fassotte,
M.F. Fassotte,
Marie France Fassotte,
Marie-France Fassotte
show all 7
Institution:
Centre Hospitalier Universitaire de Liège
Observed institutions:
Cliniques Universitaires Saint-Luc,
University of Liège,
Institut Jules Bordet,
Centre Hospitalier Universitaire de Liège
OpenAlex ID:
A5021147201
Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging
1999
·
G. Jerusalem
, Y. Beguin
, et al.
·
Blood
·
557
Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation
1992
·
D. De Groote
, P.F. Zangerle
, et al.
·
Cytokine
·
471
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)
2001
·
G. Jerusalem
, Y. Beguin
, et al.
·
Annals of Oncology
·
268
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease
2002
·
G. Jerusalem
, Y. Beguin
, et al.
·
Annals of Oncology
·
213
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.
2000
·
G Jerusalem
, Y Beguin
, et al.
·
PubMed
·
204
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
2001
·
G Jerusalem
, Y Beguin
, et al.
·
PubMed
·
203
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkinʼs disease and non-Hodgkinʼs lymphoma
1999
·
G. JERUSALEM
, V. WARLAND
, et al.
·
Nuclear Medicine Communications
·
156
18F-FDG PET in children with lymphomas
2004
·
Gisele Depas
, Caroline De Barsy
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
114
Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies
2003
·
Marc André
, Etienne Baudoux
, et al.
·
Transfusion
·
47
Primary central nervous system lymphoma
2004
·
Annie Dubuisson
, Bruno Kaschten
, et al.
·
Clinical Neurology and Neurosurgery
·
37
Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
2003
·
Roland Hustinx
, Christian Lemaire
, et al.
·
PubMed
·
37
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
1999
·
B Sautois
, V Fraipont
, et al.
·
PubMed
·
21
Limited usefulness of CA125 measurement in the management of Hodgkin's and non‐Hodgkin's lymphoma
2007
·
Christophe Bonnet
, Yves Beguin
, et al.
·
European Journal Of Haematology
·
18
Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion
2009
·
Bettina Bisig
, Christiane Copie-Bergman
, et al.
·
Human Pathology
·
16
Herpes Simplex Virus Type-I and Pyogenic Granuloma: A Vascular Endothelial Growth Factor-Mediated Association
2013
·
L. el Hayderi
, D. Paurobally
, et al.
·
Case Reports in Dermatology
·
13
PDF
Simultaneous Reactivation of Herpes simplex Virus and Varicella-Zoster Virus in a Patient with Idiopathic Thrombocytopenic Purpura
1999
·
A.F. Nikkels
, P. Frère
, et al.
·
Dermatology
·
13
Neutrophilic Eccrine Hidradenitis. A Case Report
1993
·
A.F. Nikkels
, I. Hansen
, et al.
·
Acta Clinica Belgica
·
9
Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD).
2000
·
Guy Jérusalem
, Yves Béguin
, et al.
·
ORBi (University of Liège)
·
5
1007 Accuracy of end of treatment 18F-FDG PET for predicting relapse in patients with Hodgkin's disease (HD) and Non-Hodgkin's lymphoma (NHL)
2003
·
G. Jerusalem
, V. Warland
, et al.
·
European Journal of Cancer Supplements
·
4
Translocation (2;3)(p21;q26) as the Sole Anomaly in a Case of Primary Myelofibrosis
1999
·
Christian Herens
, Jean-Philippe Hermanne
, et al.
·
Cancer Genetics and Cytogenetics
·
4
PDF
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
1998
·
F Baron
, J P Hermanne
, et al.
·
PubMed
·
4
Back pain and renal failure
2004
·
Pierre Delanaye
, Christophe Bovy
, et al.
·
The Lancet
·
3
99mTc rh-Annexin V (ApomateTM) as a marker of apoptosis resulting from chemotherapy : preliminary results.
2000
·
Tarik Belhocine
, Roland Hustinx
, et al.
·
ORBi (University of Liège)
·
3
Whole-body FDG PET imaging as a method for staging and early assessment of treatment response in pediatric patients with lymphoma.
2003
·
De Barsy
, Gisèle Depas
, et al.
·
ORBi (University of Liège)
·
2
Evaluation thérapeutique précoce par tomographie à émission de positons
2000
·
Guy Jérusalem
, Yves Béguin
, et al.
·
ORBi (University of Liège)
·
2
Show more works
View as search
Works count:
47
Citation count:
2,428
H-index:
14
I10-index:
16
Year
Topic
Type
